GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

NanoSphere Health Sciences NSHS.CN · CAD

Health Care · Canadian Securities Exchange · 🇨🇦 Canada

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in USD, from our data supplier.

FY2022

Revenue

—

FY2014FY2022

Net income

−$281,800

FY2014FY2022

Free cash flow

−$67,700

FY2014FY2022

Shareholders' equity

−$1.3m

FY2014FY2022

Income statement

Fiscal years

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue———$218,000$37,900——$15,300$6,200
Research and development$26,900$59,500—$4,800$124,000———$90,400
Operating income−$283,900−$386,000−$565,600−$2.2m−$4.0m−$1.1m−$514,200−$1.0m−$528,100
Net income−$281,800−$356,300−$591,200−$3.5m−$4.5m−$9.9m−$514,200−$1.0m−$528,100
Diluted earnings per share-0.03-0.05-0.11-0.65-0.93-2.06-0.11-0.01-0.01

Balance sheet

At each fiscal year end

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$60,100$132,500$55,200$333,700$1.3m$3.8m$516,500$44,900$19,800
Cash and short-term investments$55,000$130,800$13,000$33,500$211,600$3.7m$436,400$38,600$12,300
Total liabilities$1.4m$1.2m$1.5m$1.3m$481,300$167,400$845,800$465,200$318,200
Debt——$73,700$149,500——$631,500$465,200—
Shareholders' equity−$1.3m−$1.1m−$1.5m−$919,500$837,900$3.7m−$329,300−$420,200−$298,400
Shares outstanding10m7m5m5m5m5m5m97m97m

Cash flow

Fiscal years

FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations−$67,700−$64,700−$47,300−$1.1m−$3.2m−$1.3m−$298,600−$494,900−$532,300
Capital spending———−$53,000−$302,200−$5,100——−$8,500
Free cash flow−$67,700−$64,700−$47,300−$1.1m−$3.5m−$1.3m−$298,600−$494,900−$540,800

Latest quarters

By quarter end

Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
Operating income−$52,400−$35,600−$41,800−$48,000−$47,000−$56,700−$32,000−$63,400
Net income−$9,500−$15,800−$97,200$407,400−$41,700−$61,100−$41,300−$54,900
Diluted earnings per share-0.00-0.00-0.010.04-0.00-0.01-0.00-0.01
Total assets$16,300$17,500$14,000$13,600$22,900$33,000$17,900$18,000
Cash and short-term investments$2,500$4,100$1,800$2,000$11,800$22,700$8,100$9,300
Debt$48,600$48,400$35,000$30,700$32,000$30,800——
Shareholders' equity−$1.4m−$1.4m−$1.3m−$1.2m−$1.7m−$1.6m−$1.6m−$1.6m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-49.3%-24.4%—
Net income-56.7%-50.9%—

Valuation history

At each fiscal year end

FY2019FY2018FY2016FY2015FY2014
Price to earnings——-0.0-0.1-0.1
Price to sales0.00.1—6.88.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 20-to-1 reverse split · 7 Jul 2021
  • 5-to-1 reverse split · 5 May 2014
  • 15-to-1 reverse split · 26 Mar 2014
  • 7-to-1 reverse split · 26 Nov 2008
  • 2-to-1 reverse split · 4 Jun 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.